Birzeit Pharmaceutical Company

Birzeit Pharmaceutical Company was founded in 1974 in Birzeit, a town located 10 km away from Ramallah. Initially, BPC started as a private joint stock company with a total capital investment of $150,000.

In 1979, it transformed into a public joint stock company with a capital of 0.5 million US Dollars.

In 1992, Birzeit Pharmaceutical Company merged with the Palestine Pharmaceutical Manufacturing Company, which was the third largest pharmaceutical company in Palestine at that time. Additionally, it established MEDIX the skincare company, representing renowned international brands like Maybelline, Vichy, and Andola.

The company expanded its portfolio in 2000 by acquiring 73% of the shares of the Eastern Chemical Company.

In 2001, BPC obtained the ISO 9001 certificate, further enhancing its credibility.

It later acquired the remaining 27% in 2004. In the same year, BPC obtained the ISO 14001 certificate, demonstrating its commitment to environmental standards.

In 2005, Birzeit Pharmaceutical Company became listed on the Palestine Stock Exchange, solidifying its position in the market.

In 2008, it obtained GMP certification according to the standards set by the World Health Organization.

In 2010, the company experienced significant growth in its export market share, leading to increased revenues.